Trials / Completed
CompletedNCT03923296
PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients to Optimize Delivery of Systemic Therapy.
PERTH 2: Co-design of a Home-based Monitoring Service for Cancer Patients, Carers and Health Care Professionals to Optimize Delivery of Systemic Therapy.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 62 (actual)
- Sponsor
- Entia Ltd · Industry
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
Iterative co-design study where patients receiving systemic cancer therapy, carers and healthcare professionals involved in delivering cancer therapy, work with Entia to design a home based blood monitoring service. The iterative process means that at each stage of the development process, Entia will be building on what is learnt in the previous stage.
Detailed description
The study will use feedback provided by patients, carers and heatlhcare professionals to inform the changes that are necessary to develop a successful, user friendly home-based blood monitoring service for cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Blood measurement and monitoring | Blood from a single fingerprick will be used to used to measure and monitor patients blood parameters. |
| BEHAVIORAL | Interviews | Focus group interviews |
Timeline
- Start date
- 2019-05-20
- Primary completion
- 2021-07-16
- Completion
- 2021-07-16
- First posted
- 2019-04-22
- Last updated
- 2022-04-06
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03923296. Inclusion in this directory is not an endorsement.